BCR/ABL Directly Inhibits Expression of SHIP, an SH2-Containing Polyinositol-5-Phosphatase Involved in the Regulation of Hematopoiesis

REFERENCES

• Afar, D. E., A. Goga, J. McLaughlin, O. N. Witte, and J. Sawyers 1994. Differential complementation of BCR-ABL point mutants with c-Myc. Science 264:424–426.
   PubMed Web of Science ®Google Scholar
• Aman, M. J., T. D. Lamkin, H. Okada, T. Kurosaki, and J. Ravichandran 1998. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J. Biol. Chem. 273:33922–33928.
   PubMed Web of Science ®Google Scholar
• Andoniou, C. E., C. Thien, and J. Langdon 1994. Tumour induction by activated Abl involves tyrosine phosphorylation of the product of the Cbl oncogene. EMBO J. 13:4515–4523.
   PubMed Web of Science ®Google Scholar
• Bedi, A., B. A. Zehnbauer, J. P. Barber, S. J. Sharkis, and J. Jones 1994. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83:2038–2044.
   PubMed Web of Science ®Google Scholar
• Ben-Neriah, Y., G. Q. Daley, A. M. Mes-Masson, O. N. Witte, and J. Baltimore 1986. The chronic myelogenous leukemia-specific p210 protein is the product of the BCR/ABL hybrid gene. Science 233:212–214.
   PubMed Web of Science ®Google Scholar
• Burgess, G. S., E. A. Williamson, L. D. Cripe, S. Litz-Jackson, J. A. Bhatt, K. Stanley, M. J. Stewart, A. S. Kraft, H. Nakshatri, and J. Boswell 1998. Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase. Blood 92:2450–2460.
   PubMed Web of Science ®Google Scholar
• Canellos, G. 1991. Diagnosis and treatment of chronic granulocytic leukemia, p. 61–76. In P. H. Wiernik, G. P. Canellos, R. A. Kyle et al. (ed.), Neoplastic disease of the blood. Churchill Livingstone, New York, N.Y.
   Google Scholar
• Carlesso, N., D. A. Frank, and J. Griffin 1996. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by BCR/ABL. J. Exp. Med. 183:811–820.
   PubMed Web of Science ®Google Scholar
• Chacko, G. W., S. Tridandapani, J. E. Damen, L. Liu, G. Krystal, and J. Coggeshall 1996. Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP. J. Immunol. 157:2234–2238.
   PubMedGoogle Scholar
• Daheron, L., S. Salmeron, S. Patri, A. Brizard, F. Guilhot, J. C. Chomel, and J. Kitzis 1998. Identification of several genes differentially expressed during progression of chronic myelogenous leukemia. Leukemia 12:326–332.
   PubMedGoogle Scholar
• Dai, Z. H., and J. Pendergast 1995. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev. 9:2569–2582.
   PubMed Web of Science ®Google Scholar
• Dai, Z. H., R. C. Quackenbush, K. D. Courtney, M. Grove, D. Cortez, G. W. Reuther, and J. Pendergast 1998. Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev. 12:1415–1424.
   PubMed Web of Science ®Google Scholar
• Daley, G. Q., R. A. Van Etten, and J. Baltimore 1990. Induction of chronic myelogenous leukemia in mice by the p210BCR/ABL gene of the Philadelphia chromosome. Science 247:824–830.
   PubMed Web of Science ®Google Scholar
• Damen, J. E., L. Liu, P. Rosten, R. K. Humphries, A. B. Jefferson, P. W. Majerus, and J. Krystal 1996. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc. Natl. Acad. Sci. USA 93:1689–1693.
   PubMed Web of Science ®Google Scholar
• Damen, J. E., L. Liu, M. D. Ware, M. Ermolaeva, P. W. Majerus, and J. Krystal 1998. Multiple forms of the SH2-containing inositol phosphatase, SHIP, are generated by C-terminal truncation. Blood 92:1199–1205.
   PubMed Web of Science ®Google Scholar
• Dick, L. R., A. A. Cruikshank, A. T. Destree, L. Grenier, T. A. McCormack, F. D. Melandri, S. L. Nunes, V. J. Palombella, L. A. Parent, L. Plamondon, and J. Stein 1997. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem. 272:182–188.
   PubMed Web of Science ®Google Scholar
• Druker, B. J., S. Tamura, E. Buchdunger, S. Ohno, G. M. Segal, S. Fanning, J. Zimmermann, and J. Lydon 1996. Effects of a selective inhibitor of the ABL tyrosine kinase on the growth of BCR-ABL positive cells. Nat. Med. 2:561–566.
   PubMed Web of Science ®Google Scholar
• Elefanty, A. G., I. K. Hariharan, and J. Cory 1990. BCR-ABL, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J. 9:1069–1078.
   PubMed Web of Science ®Google Scholar
• Fruman, D. A., S. B. Snapper, C. M. Yballe, L. Davidson, J. Y. Yu, F. W. Alt, and J. Cantley 1999. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85 alpha. Science 283:393–397.
   PubMed Web of Science ®Google Scholar
• Gharehbaghi, K., G. S. Burgess, F. R. Collart, S. Litz-Jackson, E. Huberman, H. N. Jayaram, and J. Boswell 1994. p210 BCR-ABL confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene. Leukemia 8:1257–1263.
   PubMedGoogle Scholar
• Golub, T. R., A. Goga, G. F. Barker, D. Afar, J. McLaughlin, S. K. Bohlander, J. D. Rowley, O. N. Witte, and J. Gilliland 1996. Oligomerization of the Abl tyrosine kinase by the Ets protein Tel in human leukemia. Mol. Cell. Biol. 16:4107–4116.
   PubMed Web of Science ®Google Scholar
• Gordon, M. Y., C. R. Dowding, G. P. Riley, J. M. Goldman, and J. Greaves 1987. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328:342–344.
   PubMed Web of Science ®Google Scholar
• Grignani, F., T. Kinsella, A. Mencarelli, M. Valtieri, D. Riganelli, F. Grignani, L. Lanfrancone, C. Peschle, G. P. Nolan, and J. Pelicci 1998. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid ebv/retroviral vector expressing the green fluorescence protein. Cancer Res. 58:14–19.
   PubMed Web of Science ®Google Scholar
• Habib, T., J. A. Hejna, R. E. Moses, and J. Decker 1998. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein. J. Biol. Chem. 273:18605–18609.
   PubMed Web of Science ®Google Scholar
• Heisterkamp, N., G. Jenster, J. ten Hoeve, D. Zovich, P. K. Pattengale, and J. Groffen 1990. Acute leukaemia in BCR/ABL transgenic mice. Nature 344:251–253.
   PubMed Web of Science ®Google Scholar
• Heisterkamp, N., J. R. Stephenson, J. Groffen, P. F. Hansen, A. de Klein, C. R. Bartram, and J. Grosveld 1983. Localization of the c-Abl oncogene adjacent to a translocation breakpoint in chronic myelocytic leukaemia. Nature 306:239–242.
   PubMed Web of Science ®Google Scholar
• Hejna, J. A., H. Saito, L. S. Merkens, T. V. Tittle, P. M. Jakobs, M. A. Whitney, M. Grompe, A. S. Friedberg, and J. Moses 1995. Cloning and characterization of a human cDNA (INNPL1) sharing homology with inositol polyphosphate phosphatases. Genomics 29:285–287.
   PubMedGoogle Scholar
• Helgason, C. D., J. E. Damen, P. Rosten, R. Grewal, P. Sorensen, S. M. Chappel, A. Borowski, F. Jirik, G. Krystal, and J. Humphries 1998. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12:1610–1620.
   PubMed Web of Science ®Google Scholar
• Hunter, M. G., and J. Avalos 1998. Phosphatidylinositol 3′-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J. Immunol. 160:4979–4987.
   PubMed Web of Science ®Google Scholar
• Ilaria, R. L., and J. Vanetten 1996. P210 and p190BCR/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 271:31704–31710.
   PubMed Web of Science ®Google Scholar
• Jiang, X., T. Fujisaki, M. Berger, A. Eaves, and J. Eaves 1998. Abst. 1041: autonomous multi-lineage differentiation in vitro of primitive Ph+ CD34+ cells from patients with chronic myelogenous leukemia (CML). Blood Suppl. 90:254a.
   Google Scholar
• Kelliher, M. A., J. McLaughlin, O. N. Witte, and J. Rosenberg 1990. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc. Natl. Acad. Sci. USA 87:6649–6653.
   PubMed Web of Science ®Google Scholar
• Klucher, K. M., D. V. Lopez, and J. Daley 1998. Secondary mutation maintains the transformed state in BaF3 cells with inducible Bcr/Abl expression. Blood 91:3927–3934.
   PubMedGoogle Scholar
• Lamontagne, K. R., A. J. Flint, B. R. Franza, A. M. Pendergast, and J. Tonks 1998. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo. Mol. Cell. Biol. 18:2965–2975.
   PubMedGoogle Scholar
• Lioubin, M. N., P. A. Algate, S. Tsai, K. Carlberg, R. Aebersold, and J. Rohrschneider 1996. p150-SHIP, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 10:1084–1095.
   PubMed Web of Science ®Google Scholar
• Lucas, D. M., and J. Rohrschneider 1999. A novel spliced form of SH2-containing inositol phosphatase is expressed during myeloid development. Blood 93:1922–1933.
   PubMed Web of Science ®Google Scholar
• Matsuguchi, T., R. Salgia, M. Hallek, M. Eder, B. Druker, T. Ernst, and J. Griffin 1994. SHC phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interkeukin-3, and steel factor and is constitutively increased by p210BCR/ABL. J. Biol. Chem. 269:5016–5021.
   PubMed Web of Science ®Google Scholar
• McWhirter, J. R., D. L. Galasso, and J. Wang 1993. A coiled-coil oligomerization domain of BCR is essential for the transforming function of BCR-ABL oncoproteins. Mol. Cell. Biol. 13:7587–7595.
   PubMed Web of Science ®Google Scholar
• Odai, H., K. Sasaki, A. Iwamatsu, Y. Hanazono, T. Tanaka, K. Mitani, Y. Yazaki, and J. Hirai 1995. The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or EPO and constitutively binds to the SH3 domain of GRB2/ASH in human hematopoietic cells. J. Biol. Chem. 270:10800–10805.
   PubMed Web of Science ®Google Scholar
• Osborne, M. A., G. Zenner, M. Lubinus, X. L. Zhang, Z. Songyang, L. C. Cantley, P. Majerus, P. Burn, and J. Kochan 1996. The inositol 5′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J. Biol. Chem. 271:29271–29278.
   PubMed Web of Science ®Google Scholar
• Pear, W. S., G. P. Nolan, M. L. Scott, and J. Baltimore 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, and J. Gishizky 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175–185.
   PubMed Web of Science ®Google Scholar
• Pesesse, X., S. Deleu, F. Desmedt, L. Drayer, and J. Erneux 1997. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem. Biophys. Res. Commun. 239:697–700.
   PubMed Web of Science ®Google Scholar
• Puil, L., J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P. G. Pelicci, R. Arlinghaus, and J. Pawson 1994. BCR-ABL oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13:764–773.
   PubMed Web of Science ®Google Scholar
• Renshaw, M. W., J. R. McWhirter, and J. Wang 1995. The human leukemia oncogene BCR-ABL abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol. Cell. Biol. 15:1286–1293.
   PubMed Web of Science ®Google Scholar
• Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and J. Goldberg 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761–771.
   PubMed Web of Science ®Google Scholar
• Rowley, J. D. 1973. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290–293.
   PubMed Web of Science ®Google Scholar
• Salgia, R., J. L. Li, D. S. Ewaniuk, W. Pear, E. Pisick, S. A. Burky, T. Ernst, M. Sattler, L. B. Chen, and J. Griffin 1997. BCR/ABL induces multiple abnormalities of cytoskeletal function. J. Clin. Investig. 100:46–57.
   PubMed Web of Science ®Google Scholar
• Salgia, R., J. L. Li, S. H. Lo, B. Brunkhorst, G. S. Kansas, E. S. Sobhany, Y. P. Sun, E. Pisick, M. Hallek, T. Ernst, R. Tantravahi, L. B. Chen, and J. Griffin 1995. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by p210BCR/ABL. J. Biol. Chem. 270:5039–5047.
   PubMed Web of Science ®Google Scholar
• Sattler, M., M. A. Durstin, D. A. Frank, K. Okuda, K. Kaushansky, R. Salgia, and J. Griffin 1995. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp. Hematol. 23:1040–1048.
   PubMed Web of Science ®Google Scholar
• Sattler, M., R. Salgia, M. A. Durstin, K. V. Prasad, and J. Griffin 1997. Thrombopoietin induces activation of the phosphatidylinositol-3′ kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL. J. Cell. Physiol. 171:28–33.
   PubMedGoogle Scholar
• Sattler, M., R. Salgia, G. Shrikhande, S. Verma, J. L. Choi, L. R. Rohrschneider, and J. Griffin 1997. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors. Oncogene 15:2379–2384.
   PubMed Web of Science ®Google Scholar
• Sattler, M., T. Winkler, S. Verma, C. H. Byrne, G. Shrikhande, R. Salgia, and J. Griffin 1999. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93:2928–2935.
   PubMed Web of Science ®Google Scholar
• Serve, H., N. S. Yee, G. Stella, L. Sepp-Lorenzino, J. C. Tan, and J. Besmer 1995. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 14:473–483.
   PubMed Web of Science ®Google Scholar
• Shi, Y. G., K. Alin, and J. Goff 1995. Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-Abl transforming activity. Genes Dev. 9:2583–2597.
   PubMed Web of Science ®Google Scholar
• Shtivelman, E., B. Lifshitz, R. P. Gale, and J. Canaani 1985. Fused transcript of Abl and Bcr genes in chronic myelogenous leukaemia. Nature 315:550–554.
   PubMed Web of Science ®Google Scholar
• Shuai, K., J. Halpern, J. ten Hoeve, X. P. Rao, and J. Sawyers 1996. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247–254.
   PubMed Web of Science ®Google Scholar
• Skorski, T., P. Kanakaraj, M. Nieborowska-Skorska, M. Z. Ratajczak, S. C. Wen, G. Zon, A. M. Gewirtz, B. Perussia, and J. Calabretta 1995. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood 86:726–736.
   PubMed Web of Science ®Google Scholar
• Srinivasan, S., M. Seaman, Y. Nemoto, L. Daniell, S. F. Suchy, S. Emr, P. Decamilli, and J. Nussbaum 1997. Disruption of three phosphatidylinositol-polyphosphate 5-phosphatase genes from Saccharomyces cerevisiae results in pleiotropic abnormalities of vacuole morphology, cell shape, and osmohomeostasis. Eur. J. Cell Biol. 74:350–360.
   PubMedGoogle Scholar
• Stewart, M. J., S. Litz-Jackson, G. S. Burgess, E. A. Williamson, D. S. Leibowitz, and J. Boswell 1995. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells. Leukemia 9:1499–1507.
   PubMed Web of Science ®Google Scholar
• Suzuki, H., Y. Terauchi, M. Fujiwara, S. Aizawa, Y. Yazaki, T. Kadowaki, and J. Koyasu 1999. Xid-like immunodeficiency in mice with disruption of the p85 alpha subunit of phosphoinositide 3-kinase. Science 283:390–392.
   PubMed Web of Science ®Google Scholar
• Traenckner, E. B., S. Wilk, and J. Baeuerle 1994. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13:5433–5441.
   PubMed Web of Science ®Google Scholar
• Verfaillie, C. M., R. Hurley, B. I. Lundell, C. H. Zhao, and J. Bhatia 1997. Integrin-mediated regulation of hematopoiesis—do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors. Acta Haematol. 97:40–52.
   PubMedGoogle Scholar
• Verfaillie, C. M., J. B. McCarthy, and J. McGlave 1992. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J. Clin. Investig. 90:1232–1241.
   PubMed Web of Science ®Google Scholar
• Vollenweider, P., M. Clodi, S. S. Martin, T. Imamura, W. M. Kavanaugh, and J. Olefsky 1999. An SH2 domain-containing 5 ′ inositolphosphatase inhibits insulin-induced GLUT4 translocation and growth factor-induced actin filament rearrangement. Mol. Cell. Biol. 19:1081–1091.
   PubMedGoogle Scholar
• Wisniewski, D., A. Strife, S. Swendeman, H. Erdjument-Bromage, S. Geromanos, W. M. Kavanaugh, P. Tempst, and J. Clarkson 1999. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 93:2707–2720.
   PubMed Web of Science ®Google Scholar